Barclays
HAAC

Barclays’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Barclays’s Portfolio HAAC Stock Details HAAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33,064
Closed -$330K – 5585
2022
Q3 		$330K Buy
+33,064
New +$329K ﹤0.01% 2922

Other funds holding HAAC

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's HAAC Position: Q4 2022 in Review

Barclays sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q4 2022, closing a stake of 33,064 shares — an estimated $330K sold.

Barclays first reported a position in HAAC in Q3 2022 and held it in 1 quarter. The position peaked at $330K in Q3 2022. 1 fund tracked by Wall St. Rank holds HAAC as of Q4 2022.

  • Barclays reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Barclays sold 33,064 Health Assurance Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $330K.
  • Barclays first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Barclays's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $330K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.